|
MechanismMAO-B inhibitors |
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismD2 receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Delalande SA
0 Patents (Medical) associated with Delalande SA
100 Deals associated with Delalande SA
100 Translational Medicine associated with Delalande SA